Analyst Price Targets — IART
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 16, 2026 2:05 pm | — | Truist Financial | $19.00 | $19.75 | TheFly | Integra LifeSciences price target raised to $19 from $14 at Truist |
| July 8, 2026 8:33 pm | — | BMO Capital | $19.00 | $17.30 | TheFly | BMO starts 'show-me story' Integra LifeSciences with a Market Perform |
| June 18, 2026 11:50 am | — | Argus Research | $25.00 | $17.20 | TheFly | Integra LifeSciences upgraded to Buy from Hold at Argus |
| April 15, 2026 12:28 pm | Richard Newitter | Truist Financial | $12.00 | $11.01 | TheFly | Integra LifeSciences price target lowered to $12 from $13 at Truist |
| October 15, 2025 12:34 pm | — | Truist Financial | $15.00 | $14.76 | TheFly | Integra LifeSciences price target raised to $15 from $13 at Truist |
| October 7, 2024 5:33 am | Ryan Zimmerman | BTIG | $20.00 | $17.43 | StreetInsider | BTIG Upgrades Integra LifeSciences (IART) to Neutral |
| July 30, 2024 8:59 am | Richard Newitter | Truist Financial | $26.00 | $24.59 | TheFly | Integra LifeSciences price target lowered to $26 from $32 at Truist |
| July 30, 2024 3:24 am | Joanne Wuensch | Citigroup | $23.00 | $25.42 | StreetInsider | Citi Downgrades Integra LifeSciences (IART) to Sell |
| July 29, 2024 4:12 pm | Ryan Zimmerman | BTIG | $22.00 | $25.42 | TheFly | Integra LifeSciences downgraded to Sell from Neutral at BTIG |
| July 16, 2024 7:33 am | Richard Newitter | Truist Financial | $32.00 | $29.84 | TheFly | Integra LifeSciences price target raised to $32 from $25 at Truist |
Latest News for IART
Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open.
Integra LifeSciences has climbed 52.1% in a year as growth across both segments, improved execution and transformation efforts continue to boost results.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.